Evaluation of the current disease severity scores in paediatric FMF: Is it necessary to develop a new one?

Rheumatology

Volumn 51, Issue 4, 2012, Pages 743-748

  Kalkan, Gokhan ^a   Demirkaya, Erkan ^a   Acikel, Cengiz Han ^a   Polat, Adem ^a   Peru, Harun ^b   Karaoglu, Abdulbaki ^a   Sari, Erkan ^a   Dursun, Ismail ^c   Gok, Faysal ^a   Ozen, Seza ^d  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Selcuklu University   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Children; Disease severity assessment; Familial Mediterranean fever; Outcome measurement

Indexed keywords

ARTICLE; CHILD; CHILDHOOD DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SEVERITY SCORE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION MAPPING; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84858650514     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker421     Document Type: Article

References (24)

1. Cassidy JT, Petty RE. Textbook of Pediatric Rheumatology, 3rd edn. Philadelphia: Saunders, 1995.
2. Piram M, Frenkel J, Gattorno M et al. A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto-Inflammatory Diseases Activity Index) Consensus Conference. Ann Rheum Dis 2011;70:309-14.
3. Mor A, Shinar Y, Zaks N et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 2005;35:57-64.
4. Pras E, Livneh A, Balow JE Jr et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998;75: 216-9.
5. Ozen S, Aktay N, Lainka E et al. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 2009;68: 246-8.
6. Dewalle M, Domingo C, Rozenbaum M et al. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 1998;6:95-7.
7. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001;9:473-83.
8. Majeed HA, El-Shanti H, Al-Khateeb MS et al. Genotype/phenotype correlations in Arab patients with familial Mediterranean fever. Semin Arthritis Rheum 2002;31: 371-6.
9. Mansour I, Delague V, Cazeneuve C et al. Familial Mediterranean fever in Lebanon: mutation spectrum, evidence for cases in Maronites, Greek orthodoxes, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations. Eur J Hum Genet 2001;9:51-5.
10. Shinar Y, Livneh A, Langevitz P et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 2000;27: 1703-7.
11. Yalcinkaya F, Cakar N, Misirlioglu M et al. Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology 2000;39:67-72.
12. Livneh A, Langevitz P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85.
13. Sohar E, Gafni J, Pras M. Tel Hashomer key to severity score for FMF. In: Sohar E, Gafni J, Pras M, eds. Proceedings of the First International Conference of FMF. Tel Aviv: Freund Publishing House, Ltd, 1997:208.
14. Swinscow TDV. Statistics at Square One, 9th edn. London: British Medical Association, 1997.
15. Dusunsel R, Dursun I, Gunduz Z et al. Genotypephenotype correlation in children with familial Mediterranean fever in a Turkish population. Pediatr Int 2008;50:208-12.
16. Soylemezoglu O, Arga M, Fidan K et al. Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation. J Rheumatol 2010;37:182-9.
17. Brik R, Shinawi M, Kepten I et al. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 1999;103:e70.
18. Kone Paut I, Dubuc M, Sportouch J et al. Phenotypegenotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology 2000;39:1275-9.
19. Shohat M, Magal N, Shohat T et al. Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 1999;7:287-92.
20. Kallinich T, Haffner D, Niehues T et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 2007;119:e474-83.
21. Dinarello CA. IL-1: discoveries, controversies and future directions. Eur J Immunol 2010;40:599-606.
22. Dinarello CA. Interleukin-1beta and the autoinflammatory diseases. N Engl J Med 2009;360:2467-70.
23. Meinzer U, Quartier P, Alexandra JF et al. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 2011;41:265-71.
24. Ozen S, Frenkel J, Ruperto N et al. The Eurofever Project: towards better care for autoinflammatory diseases. Eur J Pediatr 2011;170:445-52.